Carotid Ultrasound to Identify Head and Neck Cancer Survivors With High Cardiovascular Risk After Radiation Therapy
A Pilot Study of Carotid Ultrasound to Identify Head and Neck Cancer Survivors With High Cardiovascular Risk After Radiation Therapy
Sponsor: Wake Forest University Health Sciences
Listed as NCT05490875, this observational or N/A phase trial focuses on Cardiovascular Complication and Carotid Artery Stenosis and remains completed. Sponsored by Wake Forest University Health Sciences, it has been updated 10 times since 2022, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
10 versions recorded-
Feb 2025 — Present [monthly]
Completed
-
Dec 2024 — Feb 2025 [monthly]
Completed
Status: Recruiting → Completed
-
Sep 2024 — Dec 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jan 2024 — Jul 2024 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Sep 2023 — Jan 2024 [monthly]
Recruiting
-
Jan 2023 — Sep 2023 [monthly]
Recruiting
-
Dec 2022 — Jan 2023 [monthly]
Recruiting
-
Nov 2022 — Dec 2022 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2022 — Nov 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .